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1 Authors having equally contributed to this work.2,3-Butanediol dehydrogenase (BDH) catalyzes the NAD-dependent redox reaction between acetoin
and 2,3-butanediol. There are three types of homologous BDH, each stereospeciﬁc for both substrate
and product. To establish how these homologous enzymes possess differential stereospeciﬁcities, we
determined the crystal structure of L-BDH with a bound inhibitor at 2.0 Å. Comparison with the
inhibitor binding mode of meso-BDH highlights the role of a hydrogen-bond from a conserved
Trp residue192. Site-directed mutagenesis of three active site residues of meso-BDH, including
Trp190, which corresponds to Trp192 of L-BDH, converted its stereospeciﬁcity to that of L-BDH. This
result conﬁrms the importance of conserved residues in modifying the stereospeciﬁcity of homolo-
gous enzymes.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Enzymatic reactions are often stereospeciﬁc and sometimes
stereoselective. Engineering the stereospeciﬁties of enzymes,
although very difﬁcult to control, has been a signiﬁcant challenge.
As in the well-known structural independence between L-lactose
dehydrogenase and D-lactose dehydrogenase, the artiﬁcial design
of enantiospeciﬁcity possessed by a native enzyme is not so simple.
2,3-Butanediol (BD) is known as a by-product of sugar metabo-
lism in microorganisms. There are three types of stereoisomer of
BD (D-, L-, and meso-forms). Since the ratio of BD stereoisomers de-
pends on the organisms and the culture conditions of the fermen-
tation process, various 2,3-butanediol dehydrogenases (BDHs)
catalyzing the redox reaction between acetoin (AC) and BD were
identiﬁed from many microorganisms. Of these BDHs, meso-BDH
from Klebsiella pneumoniae IAM 1063, speciﬁc for meso-BD and
D-AC, and L-BDH from Brevibacterium saccharolyticum C-1012, spe-chemical Societies. Published by E
, butanediol dehydrogenase;ciﬁc for L-BD and L-AC, are both biochemically and enzymatically
well characterized [1]. These two enzymes share a 50% homology
of their amino acid sequence [2,3]. Therefore, it is very interesting
to ascertain exactly how the homologous BDHs distinguish
diastereomers.
L- and meso-BDH belong to the short-chain dehydrogenase/
reductase (SDR) family, based on their amino acid sequences [3].
The substrates of SDR family enzymes vary widely in molecular
size and properties, as they include alcohols, glucose and steroids
[4]. Many crystal structures of SDR enzymes have been reported
[5], and all have core structure similar to the Rossmann fold [6].
The variable loop region located in the C-terminal side of molecule
was considered to be the reason this conserved structural frame
could recognize a wide variety of substrates [7]. There is thought
to be a common ‘‘Asn-Ser-Tyr-Lys catalytic tetrad” in SDR family
enzymes, based upon biochemical and crystallographic studies [8].
We previously determined the crystal structure of meso-BDH
from Klebsiella pneumoniae IAM 1063 at 1.7 Å resolution [9], and
here we describe X-ray crystallographic analysis of L-BDH from
B. saccharolyticum C-1012 at 2.0 Å resolution. It is now possible
to compare the chiral recognition mechanisms of the two BDHs.
We discuss the structural basis for stereospeciﬁcity on the basis
of crystallographic and site-directed mutagenesis experiments.lsevier B.V. All rights reserved.
Table 1
Summary of reﬁnement statistics.
L-BDH
Space group P1
Cell parameters a = 60.8 Å, b = 69.2 Å, c = 127.4 Å, a = 96.1, b = 100.2,
c = 109.6
Resolution (Å) 40.0–2.0
Rfactor/Rfreea 19.3/24.0
No. of non-hydrogen atoms
Protein 15,208
Coenzyme 352
Mercaptoethanol 32
Mg+ 4
Solvent 839
Rms deviations from ideal values
Bond length (Å) 0.006
Bond angles () 1.2
Ramachandran plot analysis (%)
Most favored 91.1
Allowed 8.9
a Five percent of the reﬂections were set aside for an Rfree calculation.
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2.1. Enzyme stereospeciﬁc, preparation, crystallization and X-ray data
collection
The stereospeciﬁc type of BDH, L-BDH or meso-BDH, was used
based on its stronger substrate isomer, L-BD or meso-BD, for keep-
ing consistency of the usage until now. Over-expression and puri-
ﬁcation of recombinant L-BDH were performed according to a
previously reported method [3]. L-BDH was co-crystallized with
NAD+ and mercaptoethanol (ME) by the hanging drop vapor diffu-
sion method [10]. Details of crystallization and data collection
were described [11].
2.2. Structure determination
A crystal structure of L-BDH was solved using the molecular
replacement method with the program AMORE [12] using meso-
BDH (PDB code 1GEG) [9] as a search model. Crystallographic
reﬁnements were carried out with the program CNS version 0.9
[13]. The molecular model was built using the graphics program
O [14] interpreting 2|Fo|  |Fc| and |Fo|  |Fc| electron density maps,
which were improved through several cycles of model building and
reﬁnement with CNS. The crystallographic statistics are summa-
rized in Table 1. Atomic coordinates and structure factors have
been deposited in the Protein Data Bank. The PDB ID is 3A28.
2.3. Site-directed mutagenesis, enzyme assay and kinetic analysis
Site-directed mutagenesis was performed using the Quikchange
site-directed mutagenesis kit (Stratagene). The activity of BDH was
assayed by recording the absorption of NADH at 340 nm. The stan-
dard reaction mixture consisted of 0.2 M sodium phosphate, pH
8.0, 2.5 lmol NAD+, 50 lmol BD and enzyme, in a total volume of
3.0 mL. One unit of enzyme activity was deﬁned as the amount
of enzyme that forms 1 lmol of NADH per minute at 37 C. The
Ki value of ME against BDH was determined by Dixon plots [15].
The all values obtained were averages of three trials.
3. Results and discussion
3.1. Overall structure of L-BDH
The crystal structure of L-BDH complexed with NAD+ and ME
was determined, identifying two identical homotetramers perasymmetric unit. The eight subunits (A–H) in the asymmetric unit
can be superimposed with an averaged, pairwise root-mean-
square deviation (rmsd) of 0.15 Å for 258 Ca atoms. Therefore,
the structure of subunit A will be taken hereafter as representative
of the eight subunits. The crystal structure of the L-BDH protomer
is shown in Fig. 1A. The L-BDH subunit is composed of seven b
strands, six a helices and two short a helices (aFG1 and aFG2),
which form a small lobe on top of the core domain. The conserved
active site residues Asn112, Ser141, Tyr154 and Lys158 are located
near NAD+ molecule. The roles of catalytic residues in SDR enzymes
have been intensively studied. The Tyr residue acts as a general
base for proton transfer, while the Lys residue is important in
cofactor-binding and lowering the pKa value of the hydroxyl group
of the Tyr residue. The Ser residue is suggested to be involved in
the binding of substrate, the reaction intermediate and the product
and/or the hydroxyl group of the conserved Tyr residue. The Asn
residue plays a role in maintaining the active site conﬁguration,
allowing the formation of a proton relay system involving Lys,
Tyr, the nicotinamide ribose moiety of the coenzyme and the
substrate.
A NAD+ molecule is bound to the enzyme in an extended con-
formation at the carboxyl ends of the central parallel b-sheet.
The overall conformation of NAD+ and its binding mode to the
Rossmann fold is similar to that found in other SDR enzymes
[16]. A close-up view of the binding site is shown in Fig. 1B. The
adenine ring of NAD+ binds in a hydrophobic pocket formed by
the side chains of Ile91, Val111, Asp61, Leu34 and Ala89. Hydrogen
bonds are formed by the N1 atom of adenine and the side chain
of Asp61. The adenine ribose and pyrophosphate moieties are situ-
ated on the turn formed by Gly9 and Gly15. The turn between the
ﬁrst b-strand and the second a-helix has the sequence GXXXGX,
which is a characteristic ﬁngerprint of the nucleotide-binding mo-
tif of the SDR enzymes. The 20- and 30-hydroxyl groups of the ribose
form hydrogen bonds with the side chain of Asp33, which is com-
mon to SDR enzymes that selectively bind NAD+. The pyrophos-
phate moiety interacts with the enzyme through hydrogen bonds
with the side chains of Gln12 and Thr189 and the main-chain nitro-
gen of Ile14. The nicotinamide ring moiety makes polar interactions
with the main-chain of Val187 and the side chain of Thr189. These
residues are located in the N-terminal part of aFG1. The ribose
moiety forms hydrogen bonds with the side chains of Tyr154 and
Lys158 and with the main-chain oxygen of Asn88. Other interactions
with NAD+ are similar to those seen in structures of other SDR
enzymes.
3.2. Comparison with other SDRs
A structural comparison of L-BDH with other SDR enzymes
demonstrates that L-BDH exhibits a high degree of overall struc-
tural similarity to enzymes such as meso-BDH [9], glucose dehy-
drogenase [18] and 3a, 20b-hydroxysteroid dehydrogenase [6].
Structural comparison of two BDHs reveals that L-BDH has a very
similar overall structure to meso-BDH, except for some conforma-
tional differences on the molecular surface and in the terminal re-
gions. The rmsd of the superimposed L-BDH and meso-BDH
structures is 0.5 Å. Furthermore, the manner of tetramer formation
is also identical in L-BDH and meso-BDH. Comparison of the NAD+
binding site in L-BDH and the corresponding site in meso-BDH re-
veals that the residues responsible for NAD+ binding and their spa-
tial organization are highly conserved between L-BDH and meso-
BDH. This result indicates that L-BDH binds the cofactor in the
same way as meso-BDH.
At present, the ‘Asn-Ser-Tyr-Lys catalytic tetrad’ is considered
important in SDR catalysis [5]. The catalytic tetrad residues
(Asn112, Ser141, Tyr154 and Lys158) are situated in identical positions
in meso-BDH (Asn110, Ser139, Tyr152 and Lys156). The position of the
Fig. 1. Structure of L-BDH. (A) Ribbon drawing of the L-BDH subunit with NAD+ and an inhibitor, mercaptoethanol (BME). (B) Active site structure of L-BDH. A 2|Fo|  |Fc| omit
map is superimposed on NAD+ and mercaptoethanol at the 1.0 r level. The catalytic tetrad is colored in orange. All ﬁgures showing structures in this paper were produced
with the program PYMOL [17].
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BDH and meso-BDH. This structural conservation strongly suggests
that the same reaction mechanism is common to both BDH
enzymes.
3.3. Inhibitor-binding sites
Initially, we attempted to prepare a complex of L-BDH with sub-
strate, but these efforts failed. As seen in the meso-BDH structure,
the electron density corresponding to an ME, which was included
in the crystallization solution, was observed. Kinetic analysis in
this study showed that ME was a competitive inhibitor of L-BDH
(Ki = 4.3 mM at pH 8.0). One of the most outstanding characteris-
tics of this L-BDH structure is the differential binding manner of
ME (Fig. 2). The ME molecule is located in the catalytic cleft formed
by residues Ser141, Ileu142, Ala143, Phe148, Tyr154, Pro184, Gly185,
Ileu186, Met191, Trp192 and Ile195. These residues may also be in-
volved in substrate recognition and in stereospeciﬁc redox reac-
tions. The location of the bound ME in L-BDH is roughly the same
as that in meso-BDH. The relative position of the thiol group is al-
most same in both BDHs with the same hydrogen bond from the
conserved catalytic Tyr residue (Fig. 2). The catalytic Ser residue
is also located very close to the thiol group, being 3.8 Å in L-BDH
and 4.4 Å in meso-BDH. On the other hand, the hydroxyl group of
ME is hydrogen bonded to Gly185, similar to meso-BDH (Gly183),
and to Trp192 in L-BDH, but inconsistent with Gln140 in meso-
BDH. The distinct inhibitor binding orientation in two BDHs im-
plies that stereospeciﬁc substrate-binding is due to subtle amino
acid differences.
3.4. Substrate-binding and stereospeciﬁcity of BDHs
A structural comparison of the two types of BDHs has indicated
that both enzymes share common overall structure, cofactor-bind-
ing mode and catalytic mechanism. Therefore, L-BDH and meso-
BDH must bind their substrate in different manners. ME is a com-
petitive inhibitor with a smaller molecular size, and the number of
substituent groups is same as that of L-BD. Therefore, ME is ex-
pected to mimic the binding mode of the real substrate. Substrate
binding in the BDHs was postulated based on the product conﬁgu-
ration, the inhibitor binding mode and the stereochemical arrange-ment toward the pro-S hydride of the bound cofactor and the
catalytic residues of Tyr and Ser. The C2 and C3 chiral carbon atoms
of L-BD are both in the S conﬁguration, whereas those of meso-BD
are in the S and R conﬁguration, respectively. Thus, the only differ-
ence between L-BD and meso-BD is the conﬁguration at the C3 chi-
ral carbon. Superposition of bound ME within L-BDH and meso-
BDH implies that the binding environments are similar at the thiol
group side but they differ at the hydroxyl group side. We present
here a working hypothesis for the binding mode of L-BD and
meso-BD, referring to the binding mode of ME. The orientation of
BD is with the C2 chiral carbon at the thiol side and the C3 carbon
at the hydroxyl side. There is enough space for additional C1 and
C4 methyl groups of the substrate, in both cases of L-BD and
meso-BD. The structures of predicted substrate-binding sites in L-
BDH andmeso-BDH are shown in Fig. 3. The hydroxyl groups being
catalyzed are located within hydrogen bonding distances from the
catalytic Tyr and/or Ser, while the other hydroxyl groups with dif-
ferent stereochemistry in two BDs are hydrogen bonded distinc-
tively as seen in ME bindings.
Of the 11 residues that line the active site in L-BDH, only two are
different from those in meso-BDH. The different residues are Ile142
(Gly140 in meso-BDH) and Phe148 (Asn146 in meso-BDH). In the
meso-BDH structure, the carbonyl group of Gly183 and the side
chain NH atom of Gln140 would make hydrogen bonds with the hy-
droxyl group of meso-BD. In the L-BDH structure, the carbonyl
group of Gly185 and the side chain NH atom of Trp192 would form
hydrogen bonds with the hydroxyl group at the C3 carbon of L-
BD. Therefore, we propose that switching two kinds of hydrogen
bonds, one from a Trp residue and the other from a Gln residue,
is crucial to differentiate the stereoisomers stereospeciﬁcally. In
order to verify this hypothesis, we prepared mutant enzymes and
measured their stereoselectivities.
3.5. Stereospeciﬁcities of the mutant enzymes
In order to deduce the mechanism of chiral recognition of BDHs,
based on the shape and physiochemical properties of the sub-
strate-binding site, site-directed mutagenesis was performed. Sin-
gle and double mutants of L-BDH and meso-BDH were made, in
which the two residues that differ in the substrate-binding site be-
tween two BDHs were exchanged. As shown in Table 2, stereospec-
Fig. 2. Close-up views of the mercaptoethanol-binding site in L-BDH (A) and inmeso-BDH (B). Hydrogen bond distances and the distances from catalytic residues are depicted
as yellow broken lines.
Table 2
Speciﬁc activity of WT enzymes and their mutants.
Enzymes Speciﬁc activity (U/mg)a
meso-BD L-BD
L-BDH
Wild type 0.1 4.3 (Km: 0.1 mM)
I142Q Tb T
F148N T T
I142Q/F148N T T
meso-BDH
Wild type 177 (Km: 2.0 mM) 5.5
Q140I 0.1 0.1
N146F 19.4 1.1
Q140I/N146F 3.1 4.5
Q140I/N146F/W190H T 2.9 (Km: 70 mM)
a Value is the average obtained from three trials within ±3.2% dispersion range.
b T means trace activities under 0.1.
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activity towards L-BD and meso-BD. Although the Q140I or N146F
mutant of meso-BDH show some activity (0.1 U/mg or 19.4 U/mg,
respectively) with meso-BD as substrate, no activity was detected
in the I142Q or F148N mutant of L-BDH. In both L-BDH and meso-
BDH, neither single nor double mutations were sufﬁcient to change
the stereospeciﬁcity of BDHs.
As already discussed, 3D comparison has conﬁrmed that a con-
served tryptophan side chain provides a hydrogen bond to a sub-
strate only in the L-BDH structure (Trp192). Since it is difﬁcult to
change the side chain conformation by site-directed mutagenesis,
a non-complementary triple mutant of meso-BDH (Q140I, N146F
and W190H) was prepared in order to introduce an additional
hydrogen-bond donating site at Trp190 of meso-BDH, and the stere-
oselectivities were measured. The stereospeciﬁcity of the triple
mutant ofmeso-BDH was shifted from the meso-type to the L-type.
This change might be occurred by a more pronounced decrease for
the meso-substrate. However, the mutant showed an increase in
Km value such that it was higher than wild-type L-BDH. Therefore,
an additional substitution is necessary to attain reversed
stereospeciﬁcity.
The results presented here demonstrate that while BDH stere-
oselectivity is controlled, at least in part, by tuning the orientationFig. 3. Schematic drawings of the substrate binding model for L-BD (a) and meso-BD (b).
are colored in brown.of substrate in the binding site, it still remains unclear which fac-
tors underlie the afﬁnity for substrate. Further structural analysis
of the crystallized mutants will help to clarify the subtle structural
differences at the substrate-binding site, and this will deepen our
understanding of these enzymes. Structural investigations of theHydrogen bonds are indicated with dashed lines. The catalytic Tyr and Ser residues
M. Otagiri et al. / FEBS Letters 584 (2010) 219–223 223mutants are currently under way. This information will enable fur-
ther rational engineering of the enzyme to change the topology of
the substrate-binding site and adjust substrate stereoselectivity.
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